| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/31/2008 | US20080181850 detecting the presence or absence of expression neuroligin messenger RNA or polypeptides in tumor tissues or blood of humans suspected of having prostate cancer; screening for antisense agents or drugs; medical diagnosis |
| 07/31/2008 | US20080181849 Methods, kits and compositions comprising crotamine |
| 07/31/2008 | CA2676208A1 Compound, a1 adrenergic receptor antagonist agent, and composition |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950297A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 07/30/2008 | EP1950211A1 Process for production of cinnamamide derivative |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949889A1 Fibroblast activator, method for activation of fibroblast, collagen synthesis promoter, method for promotion of collagen synthesis, skin aging-preventing agent, and method for prevention of aging of the skin |
| 07/30/2008 | EP1948661A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/30/2008 | EP1948223A1 Sumoylation control agent and uses thereof |
| 07/30/2008 | EP1948163A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 07/30/2008 | EP1948151A1 Compositions for peritoneal dialysis |
| 07/30/2008 | EP1948145A2 Protection of oxidizable agents |
| 07/30/2008 | EP1809297B1 Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 07/30/2008 | EP1542973B1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1503803B1 Injectable pharmaceutical composition comprising ethanol for treating herniated invertebral discs |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1328269B2 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 07/30/2008 | EP1315492B1 Use of substituted pyrazoles for the treatment of allergies |
| 07/30/2008 | EP1272187B1 Dopamine-d3 receptor ligands for the treatment of addiction |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | EP1041977B1 Use of ppar-gamma activators for treating dermatological disorders |
| 07/30/2008 | EP0984771B1 Stabilized gas-supersaturated emulsions and suspensions |
| 07/30/2008 | CN101232897A Angiogenetic agent containing adrenomedulin as the active ingredient |
| 07/30/2008 | CN101230375A Jellyfish original glycoprotein having fatigue resistant activity and preparation technique thereof |
| 07/30/2008 | CN101230090A Blood peptide X and derivative thereof as well as preparation method and use thereof |
| 07/30/2008 | CN101230067A Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 07/30/2008 | CN101230062A Muscarinic acetycholine receptor antagonists |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101229370A Autologous T-cell vaccines against multiple sclerosis |
| 07/30/2008 | CN101229241A Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation |
| 07/30/2008 | CN101229217A Channels and collaterals uncloging acupuncture medicine |
| 07/30/2008 | CN101229204A Process for preparing bupleurum total saponin |
| 07/30/2008 | CN101229192A Ovary cell microcapsule |
| 07/30/2008 | CN101229186A Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 07/30/2008 | CN101229185A Medicine compounds for treating seriously disease |
| 07/30/2008 | CN101229173A Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 07/30/2008 | CN101229157A Calldesartan ci1exetil medicine compounds |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406452C N-phenyl-2-pyrimidine-amine derivatives |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/30/2008 | CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406427C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/30/2008 | CN100406024C Preparing method for exogenous nitric oxide |
| 07/30/2008 | CN100406010C Antitumor agents and process for producing the same |
| 07/30/2008 | CN100406008C Pharmaceutical composition comprising lumiracoxib |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405307 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 07/29/2008 | US7405288 V-like domain binding molecules and polynucleotides encoding therefor |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405197 Controlling embryos insertion; fertility therapy; concurrent administering with follicle stimulating hormone |
| 07/29/2008 | US7405192 Difference between the amplified sequence and the normal gene sequence is diagnostic of glaucoma |
| 07/29/2008 | US7405058 Thymic stromal lymphopoietin (TSLP); nucleic acid encoding polypeptide of given sequence; use in peptide fragmentation studies and molecular weight measurements |
| 07/29/2008 | US7404953 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/29/2008 | US7404270 Tumor antigen |
| 07/29/2008 | CA2460939C Substituted pyrazolyl compounds for the treatment of inflammation |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2413670C Human brain and testis-specific immunoglobulin superfamily (bt-igsf) cdna for diagnosis of aplasia of corpus callosum and aspermatogenesis |
| 07/29/2008 | CA2387762C Process of making substituted pyrazoles |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2375383C Modulators of methylation for control of bacterial virulence |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2368413C Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2344893C Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/29/2008 | CA2223702C Therapeutic fragments of von willebrand factor |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/29/2008 | CA2192543C Interleukin-5 specific recombinant antibodies |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2008089403A2 Oligosaccharides comprising an aminooxy group and conjugates thereof |